Schedule I - Cash Flow (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Condensed Financial Statements, Captions [Line Items]
Net loss	$ (10,345)	$ 4,347	$ (5,310)	$ (9,538)	$ (8,520)	$ (4,090)	$ (20,110)	$ (12,386)	$ (20,846)	$ (45,106)	$ (81,374)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of deferred loan costs and discount									1,826	2,976	3,542
Payments-in-kind interest payments									(37,624)	(2,698)	0
Payment-in-kind interest capitalized									0	15,935	15,396
Write off of deferred loan cost and discount									3,876	3,294	0
(Benefit) Provision for deferred income tax									(1,001)	(7,051)	(8,020)
Changes in assets and liabilities related to operations:
Prepaid expenses									(895)	(599)	2,021
Accounts payable and accrued liabilities									(6,063)	8,451	12,567
Net cash provided by operating activities									45,511	44,008	34,493
Cash flows from investing activities
Net cash used in investing activities									(70,114)	(120,811)	(40,629)
Cash flows from financing activities
Proceeds from issuance of first lien credit facilities									0	448,725	0
Proceeds from Issuance of Common Stock									176,341	0	0
Repayment of seller notes									0	12,401	0
Proceeds from employees in advance of common stock issuance									0	25	75
Repurchase of shares issued to management									0	0	(50)
Payment of deferred loan costs									(41)	(3,267)	0
Net cash provided by (used in) financing activities									76,066	78,054	(11,603)
Cash, cash equivalents and restricted cash, beginning of period				19,242					19,242
Cash, cash equivalents and restricted cash, end of period	70,726				19,242				70,726	19,242
Non-cash investing and financing activities:
Incurrance of Amaya Seller Note									500	2,600	0
Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Net loss									(20,846)	(45,106)	(81,374)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of deferred loan costs and discount									0	479	340
Payments-in-kind interest payments									(37,624)	(1,108)	0
Payment-in-kind interest capitalized									0	15,933	14,819
Write off of deferred loan cost and discount									3,037	0	0
Equity in net loss of subsidiaries									16,396	28,302	62,450
(Benefit) Provision for deferred income tax									0	0	3,528
Changes in assets and liabilities related to operations:
Prepaid expenses									5	(14)	23
Intercompany payable/receivable									365	306	148
Accounts payable and accrued liabilities									0	(36)	35
Net cash provided by operating activities									(38,667)	(1,244)	(31)
Cash flows from investing activities
Investment in subsidiaries									(12,100)	(7,965)	(15,720)
Distributions received from subsidiaries									0	8,084	0
Net cash used in investing activities									(12,100)	119	(15,720)
Cash flows from financing activities
Repayment of seller notes									0	(6,870)	0
Proceeds from employees in advance of common stock issuance									0	25	0
Repurchase of shares issued to management									0	0	(50)
Net cash provided by (used in) financing activities									62,115	(6,845)	(50)
Increase (decrease) in cash cash, cash equivalents and restricted cash									11,348	(7,970)	(15,801)
Cash, cash equivalents and restricted cash, beginning of period				$ 2,201				$ 10,171	2,201	10,171	25,972
Cash, cash equivalents and restricted cash, end of period	$ 13,549				$ 2,201				$ 13,549	$ 2,201	$ 10,171